A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: Results of a Phase II study

The treatment of recurrent or progressive ovarian cancer has limited therapeutic potential. The clinical outcome of second-line therapy largely depends on the potential chemo-sensitivity of the tumor expressed during up-front chemotherapy, as well as on the treatment-free interval from the last cour...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of gynecological cancer 2001-11, Vol.11 (6), p.438-444
Hauptverfasser:	Panici, P. Benedetti, Greggi, S., Amoroso, M., Scambia, G., Battaglia, F. A., Gebbia, V., Salerno, G., Paratore, M. P., Mancuso, S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma, Clear Cell - drug therapy Adenocarcinoma, Clear Cell - pathology Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer therapies Carboplatin - administration & dosage Carboplatin - adverse effects Carcinoma, Endometrioid - drug therapy Carcinoma, Endometrioid - pathology Chemotherapy Cisplatin - administration & dosage Cisplatin - adverse effects Cystadenocarcinoma, Serous - drug therapy Cystadenocarcinoma, Serous - pathology Dose-Response Relationship, Drug Drug Administration Schedule Drug Resistance, Neoplasm Female Humans Middle Aged Ovarian cancer Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology platinum-based chemotherapy tamoxifen Tamoxifen - administration & dosage Tamoxifen - adverse effects Treatment Failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!